Both in Pharmaceuticals
Anixa Biosciences vs Nkarta
Over the past year ANIX returned −24.6% and NKTX returned −24.6%; their daily moves had a correlation of 0.22.
ANIX −24.6% NKTX −24.6%Growth of $1, one year, split-adjusted
| Metric | ANIX | NKTX |
|---|---|---|
| Price | $3.12 | $1.56 |
| Market cap | $108.5M | $111.7M |
| Today | −5.45% | −6.02% |
| 1 month | +12.6% | −39.1% |
| 6 months | −0.6% | −46.8% |
| Year to date | 0.0% | −15.7% |
| 1 year | −25.0% | −25.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.9M | $182.8M |
| Dividend yield | — | — |
| Volatility (60d) | 58.9% | 62.3% |
| Short % of float | 7.4% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).